Invention Grant
- Patent Title: Methods of treatment with anitbodies to a chemokine expressed in inflamed adenoid
- Patent Title (中): 在发炎腺样体中表达的趋化因子的治疗方法
-
Application No.: US11806846Application Date: 2007-06-04
-
Publication No.: US07708984B2Publication Date: 2010-05-04
- Inventor: Karl J. Guegler , Phillip R. Hawkins , Craig G. Wilde , Jeffrey J. Seilhamer
- Applicant: Karl J. Guegler , Phillip R. Hawkins , Craig G. Wilde , Jeffrey J. Seilhamer
- Applicant Address: US DE Wilmington
- Assignee: Incyte Corporation
- Current Assignee: Incyte Corporation
- Current Assignee Address: US DE Wilmington
- Agency: Foley & Lardner LLP
- Main IPC: A61K38/19
- IPC: A61K38/19

Abstract:
The present invention provides nucleotide and amino acid sequences that identify and encode a novel expressed chemokine (ADEC) from inflamed adenoid tissue. The present invention also provides for antisense molecules to the nucleotide sequences which encode ADEC, expression vectors for the production of purified ADEC, antibodies capable of binding specifically to ADEC, hybridization probes or oligonucleotides for the detection of ADEC-encoding nucleotide sequences, genetically engineered host cells for the expression of ADEC, diagnostic tests for inflammation or disease based on ADEC-encoding nucleic acid molecules or antibodies capable of binding specifically to ADEC.
Public/Granted literature
- US20080138346A1 Antibodies to a chemokine expressed in inflamed adenoid Public/Granted day:2008-06-12
Information query
IPC分类: